(Bloomberg) -- Six months after watching its share price soar threefold in the first two days of trading, ReWalk Robotics Ltd. is just about right back where it started.
Since the rally following its initial public offering in September, the Yokneam, Israel-based company -- which makes exoskeletons that help paraplegics walk -- has tumbled 64 percent to $13.26. That’s just 10 percent above its IPO price of $12 a share.
Investors have grown skeptical over the company’s ability to stem widening losses as it seeks to develop a market for its flagship ReWalk robotic device.
Help employers find you! Check out all the jobs and post your resume.
